Press Release: Dynavax : Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
/PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative...
Read full article »
Dynavax is a biopharmaceutical company that discovers, develops and commercializes novel vaccines for the treatment of cancer.
Read more